Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06110416 · ClinicalTrials.gov registry record · NA
Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient
A NA study, sponsored by Methodist Health System.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06110416: Completed NA study, sponsored by Methodist Health System.
NCT06110416 is a NA study that has completed, run by Methodist Health System. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06110416, a NA study, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
From the research and current studies, post-operative nausea and vomiting is a common complaint after bariatric surgery. Nausea relief inhalers could improve post-operative nausea and vomiting without the need for further medications, subsequently reducing the chance of side effects. This study could help improve patient satisfaction and increase the ability of the patient to ambulate after surgery with the use of a nausea relief inhaler.
Primary Outcome
The amount of nausea and vomiting medication use will be determined by the medication administration record during chart review in the first 24 hours for each study patient.
Interventions
- OTHER nausea relief inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2023-06-27 |
| Phase | NA |
What the finished NCT06110416 record still lists
NCT06110416 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which nausea relief inhaler is the first listed.
NCT06110416 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06110416 about?
NCT06110416 is a clinical study titled "Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient". From the research and current studies, post-operative nausea and vomiting is a common complaint after bariatric surgery. Nausea relief inhalers could improve post-operative nausea and vomiting without the need for further medications, subsequently reducing the chance of side effects. This study coul...
What is the current status of trial NCT06110416?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-12-23. Estimated completion is 2023-06-27.
What interventions are being tested in trial NCT06110416?
The interventions under investigation include: nausea relief inhaler (OTHER).
Who is sponsoring clinical trial NCT06110416?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06110416's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI